Coronavirus treatment: Indian-American physician identifies doable COVID-19 therapy

Picture Supply : AP

Coronavirus treatment: Indian-American physician identifies doable COVID-19 therapy

An Indian-American scientist has found a possible technique to stop life-threatening irritation, lung harm and organ failure in sufferers recognized with COVID-19. Revealed on-line within the journal Cell, the analysis coming from the lab of Dr Thirumala-Devi Kanneganti, an Indian-born researcher working at St. Jude Kids’s Analysis Hospital in Tennessee, recognized the medication after discovering that the hyperinflammatory immune response related to COVID-19 results in tissue harm and multi-organ failure in mice by triggering inflammatory cell demise pathways.

The researchers detailed how the inflammatory cell demise signaling pathway labored, which led to potential therapies to disrupt the method. “Understanding the pathways and mechanism driving this irritation is essential to develop efficient therapy methods,” stated Kanneganti, vice chair of the St Jude Division of Immunology.

Kanneganti was born and raised in Telangana. She obtained her undergraduate diploma at Kakatiya College in Warangal, the place she majored in Chemistry, Zoology, and Botany. She then obtained her M.Sc. and Ph.D from Osmania College in India. She joined St. Jude, in Memphis, Tennessee, USA, in 2007.

“This analysis supplies that understanding. We additionally recognized the precise cytokines that activate inflammatory cell demise pathways and have appreciable potential for therapy of COVID-19 and different extremely deadly illnesses, together with sepsis,” she stated.

The opposite researchers had been Shraddha Tuladhar, Parimal Samir, Min Zheng, Balamurugan Sundaram, Balaji Banoth, R Ok Subbarao Malireddi, Patrick Schreiner, Geoffrey Neale, Peter Vogel and Richard Webby, of St. Jude; and Evan Peter Williams, Lillian Zalduondo and Colleen Beth Jonsson, of the College of Tennessee Well being Science Heart.

COVID-19 is brought on by the SARS-CoV-2 virus. The an infection has killed greater than 1.2 million folks in lower than one yr and sickened hundreds of thousands extra.

The an infection is marked by elevated blood ranges of a number of cytokines. These small proteins are secreted primarily by immune cells to make sure a speedy response to limit the virus. Some cytokines additionally set off irritation.

The phrase cytokine storm has been used to explain the dramatically elevated cytokine ranges within the blood and different immune modifications which have additionally been noticed in COVID-19, sepsis and inflammatory issues reminiscent of hemophagocytic lymphohistiocytosis (HLH), St Jude’s stated in an announcement.

However the particular pathways that provoke the cytokine storm and the following irritation, lung harm and organ failure in COVID-19 and the opposite issues had been unclear.

The mobile and molecular mechanisms that comprehensively outline cytokine storm was additionally missing. Kanneganti’s workforce targeted on a choose set of probably the most elevated cytokines in COVID-19 sufferers. The scientists confirmed that no single cytokine induced cell demise in innate immune cells, it stated.

“The findings hyperlink inflammatory cell demise induced by TNF-alpha and IFN-gamma to COVID-19,” Kanneganti stated.

“The outcomes additionally counsel that therapies that concentrate on this cytokine mixture are candidates for speedy medical trials for therapy of not solely COVID-19, however a number of different typically deadly issues related to cytokine storm,” she stated.

“We had been excited to attach these dots to know how TNF-alpha and IFN-gamma set off PANoptosis,” stated co-first writer Rajendra Karki, a scientist within the Kanneganti laboratory.

“Certainly, understanding how PANoptosis contributes to illness and mortality is essential for figuring out therapies,” added co-first writer Bhesh Raj Sharma, a scientist within the Kanneganti laboratory. 

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *